Assessment of biological effectiveness of boron neutron capture therapy in primary and metastatic melanoma cell lines

References

• Amemiya K, Takahashi H, Kajimoto Y, Nakazawa M, Yanagie H, Hisa T, Eriguchi M, Nakagawa Y, Majima T, Kageji T, Sakurai Y, Kobayashi T, Konishi T, Hieda K, Yasuda N, Ogura K. 2005. High-resolution nuclear track mapping in detailed cellular histology using CR-39 with the contact microscopy technique. Radiat Measure 40:283–288.
   Google Scholar
• Babu E, Kanai Y, Chairoungdua A, Kim DK, Iribe Y, Tangtrongsup S, Jutabha P, Li Y, Ahmed N, Sakamoto S, Anzai N, Nagamori S, Endou H. 2003. Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters. J Biologic Chem 278:43838–43845.
   PubMed Web of Science ®Google Scholar
• Barth RF, Coderre JA, Vicente MGH, Blue TE. 2005. Boron neutron capture therapy of cancer: Current status and future prospects. Clin Cancer Res 11:3987–4002.
   PubMed Web of Science ®Google Scholar
• Barth RF, Vicente MG, Harling OK, Kiger WS 3rd, Riley KJ, Binns PJ, Wagner FM, Suzuki M, Aihara T, Kato I, Kawabata S. 2012. Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer. Radiat Oncol 7: 146–166.
   PubMed Web of Science ®Google Scholar
• Blaumann HR, González SJ, Longhino J, Santa Cruz GA, Calzetta Larrieu OA, Bonomi MR, Roth BM. 2004. Boron neutron capture therapy of skin melanomas at the RA-6 reactor: A procedural approach to beam set up and performance evaluation for upcoming clinical trials. Med Phys 31:70–80. Erratum in: Med Phys 2004;31:2373.
   PubMedGoogle Scholar
• Bodoy S, Martín L, Zorzano A, Palacín M, Estévez R, Bertran J. 2005. Identification of LAT4, a novel amino acid transporter with system L activity. J Biologic Chem 280:12002–12011.
   PubMedGoogle Scholar
• Carpano M, Dagrosa A, Nievas S, Rossini A, Juvenal G, Pisarev M. 2010. Comparative studies of boronophenylalanine (BPA) uptake in three human cell lines of malignant melanoma. Proceedings of 14th International Congress on Neutron Capture Therapy, October 25–29, Buenos Aires, Argentina. pp 123–125.
   Google Scholar
• Chandra S, Tjarks W, Lorey DR 2nd, Barth RF. 2008. Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS). J Microscopy 229:92–103.
   PubMedGoogle Scholar
• Chandra S, Barth RF, Haider SA, Yang W, Huo T, Shaikh AL, Kabalka GW. 2013. Biodistribution and subcellular localization of an unnatural boron-containing amino acid (cis-ABCPC) by imaging secondary ion mass spectrometry for neutron capture therapy of melanomas and gliomas. PLoS One 8:e75377.
   PubMedGoogle Scholar
• Coderre JA, Glass JD, Packer S, Micca P, Greenberg D. 1990. Experimental boron neutron capture therapy for melanoma: Systemic delivery of boron to melanotic and amelanotic melanoma. Pigment Cell Res 3:310–318.
   PubMedGoogle Scholar
• Coderre JA, Morris GM. 1999. The radiation biology of boron neutron capture therapy. Radiat Res 151:1–18.
   PubMed Web of Science ®Google Scholar
• Coderre JA, Turcotte JC, Riley KJ, Binns PJ, Harling OK, Kiger WS 3rd. 2003. Boron neutron capture therapy: Cellular targeting of high linear energy transfer radiation. Technol Cancer Res Treat 2: 355–375.
   PubMed Web of Science ®Google Scholar
• Dean E, Lorigan P. 2012. Advances in the management of melanoma: targeted therapy, immunotherapy and future directions. Expert Rev Anticancer Ther 12:1437–1448.
   PubMed Web of Science ®Google Scholar
• Detta A, Cruickshank GS. 2009. L-amino acid transporter-1 and boronophenylalanine-based boron neutron capture therapy of human brain tumors. Cancer Res 69:2126–2132.
   PubMedGoogle Scholar
• Franken APN, Rodermond HM, Stap J, Haveman J, van Bree C. 2006. Clonogenic assay of cells in vitro. Nature Protocols 1: 2315–2319.
   PubMed Web of Science ®Google Scholar
• Fukuda H, Hiratsuka J, Honda C, Kobayashi T, Yoshino K, Karashima H, Takahashi J, Abe Y, Kanda K, Ichihashi M, Mishima Y. 1994. Boron neutron capture therapy of malignant melanoma using B-10-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin. Radiat Res 138:435–442.
   PubMedGoogle Scholar
• Fukuda H, Hiratsuka J, Kobayashi T, Sakurai Y, Yoshino K, Karashima H, Turu K, Araki K, Mishima Y, Ichihashi M. 2003. Boron Neutron Capture Therapy (BNCT) for malignant melanoma with special reference to absorbed doses to the normal skin and tumor. Australas Phys Engineer Sci Med 26:97–103.
   PubMedGoogle Scholar
• González SJ, Bonomi MR, Santa Cruz GA, Blaumann HR, Calzetta Larrieu OA, Menéndez P, Jiménez Rebagliati R, Longhino J, Feld DB, Dagrosa MA, Argerich C, Castiglia SG, Batistoni DA, Liberman SJ, Roth BM. 2004. First BNCT treatment of a skin melanoma in Argentina: Dosimetric analysis and clinical outcome. Appl Radiat Isotopes 61:1101–1105.
   PubMedGoogle Scholar
• Gray-Schopfer V, Wellbrock C, Marais R. 2007. Melanoma biology and new targeted therapy. Nature 445:851–857.
   PubMed Web of Science ®Google Scholar
• Guerra L, Mordoh J, Slavutsky I, Larripa I, Medrano EE. 1989. Characterization of IIB-MEL-J: A new and highly heterogenous human melanoma cell line. Pigment Cell Melanoma Res 2: 504–509.
   Google Scholar
• Imahori Y, Ueda S, Ohmori Y, Sakae K, Kusuki T, Kobayashi T, Takagaki M, Ono K, Ido T, Fujii R. 1998. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: Parts I and II. Clin Cancer Res 4:1825–1832 (part I); 1833–1841(II).
   Google Scholar
• Kaira K, Sunose Y, Ohshima Y, Ishioka NS, Arakawa K, Ogawa T, Sunaga N, Shimizu K, Tominaga H, Oriuchi N, Itoh H, Nagamori S, Kanai Y, Yamaguchi A, Segawa A, Ide M, Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, Hisada T, Ishizuka T, Kanai Y, Endou H, Nakajima T, Mori M. 2009. Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in early stage squamous cell carcinoma of the lung. Cancer Sci 100:248–254.
   PubMed Web of Science ®Google Scholar
• Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H. 1998. Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biologic Chem 273:23629–23632
   PubMed Web of Science ®Google Scholar
• Konishi T, Amemiya K, Natsume T, Takeyasu A, Yasuda N, Furusawa Y, Hieda K. 2007. A new method for the simultaneous detection of mammalian cells and ion tracks on a surface of CR-39. J Radiat Res 48:255–261.
   PubMedGoogle Scholar
• Loria D, González A, Latorre C. 2008. Cutaneous melanoma epidemiology in Argentina: Analysis from the Argentine Cutaneous Melanoma Registry. Dermatol Argentina 14:436–443.
   Google Scholar
• Mackiewicz-Wysocka M, Zolnierek J, Wysocki PJ. 2013. New therapeutic options in systemic treatment of advanced cutaneous melanoma. Expert Opin Investigat Drugs 22:181–190.
   PubMed Web of Science ®Google Scholar
• Menéndez PR, Roth BMC, González SJ, Santa Cruz GA, Blaumann HR, Calzetta Larrieu OA, Feld D, Casal MR, Jimenez Rebagliati R, Nievas SI, Longhino J, Pereira MD, Fernandez CD, Kessler J, Liberman SJ. 2009. BNCT for skin melanoma in extremities: updated argentine clinical results. Appl Radiat Isotopes 67:50–53.
   PubMed Web of Science ®Google Scholar
• Miller M, Quintana J, Ojeda J, Langan S, Thorp S, Pozzi E, Sztejnberg M, Estryk G, Nosal R, Saire E, Agrazar H, Graiño F. 2009. New irradiation facility for biomedical applications at the RA-3 reactor thermal column. Appl Radiat Isotopes 67:226–229.
   Google Scholar
• Mishima Y, Ichihashi M, Hatta S, Honda C, Yamamura K, Nakagawa T. 1989. New thermal neutron capture therapy for malignant melanoma: Melanogenesis-seeking 10B molecule- melanoma cell interaction from in vitro to first clinical trial. Pigment Cell Melanoma Res 2:226–234.
   Google Scholar
• Ono K, Masunaga SI, Kinashi Y, Takagaki M, Akaboshi M, Kobayashi T, Akuta K. 1996. Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: Its relation to quiescent cell population and tumor cure in neutron capture therapy. Int J Radiat Oncol Biol Phys 34:1081–1086.
   PubMed Web of Science ®Google Scholar
• Papaspyrou M, Feinendegen LE, Müller-Gärtner HW. 1994. Preloading with L-tyrosine increases the uptake of boronophenylalanine in mouse melanoma cells. Cancer Res 54:6311–6314.
   PubMedGoogle Scholar
• Pineda M, Fernández E, Torrents D, Estévez R, López C, Camps M, Lloberas J, Zorzano A, Palacín M. 1999. Identification of a membrane protein, LAT-2, that co-expresses with 4F2 heavy chain, an L-type amino acid transport activity with broad specificity for small and large zwitterionic amino acids. J Biologic Chem 274: 19738–19744.
   PubMed Web of Science ®Google Scholar
• Rigel DS. 2010. Epidemiology of melanoma. Semin Cutan Med Surgery 29:204–209.
   PubMed Web of Science ®Google Scholar
• Rofstad EK. 1992. Radiation sensitivity in vitro of primary tumours and metastatic lesions of malignant melanoma. Cancer Res 52: 4453–4457.
   PubMedGoogle Scholar
• Rossini AE, Thomasz L, Dagrosa MA, Carpano M, Juvenal G, Pisarev M. 2010. Molecular characterization of amino acid transporter system L involved in boronophenylalanine uptake for BNCT in melanoma. Proceedings of 14th International Congress on Neutron Capture Therapy, October 25–29, Buenos Aires, Argentina. pp 123–125.
   Google Scholar
• Santa Cruz GA, Zamenhof RG. 2004. The microdosimetry of the (10)B reaction in boron neutron capture therapy: A new generalized theory. Radiat Res 162:702–710.
   PubMed Web of Science ®Google Scholar
• Selzer E, Hebar A. 2012. Basic principles of molecular effects of irradiation. Wiener Medizin Wochenschrift 162:47–54.
   PubMedGoogle Scholar
• Suzuki M, Masunaga SI, Kinashi Y, Takagaki M, Sakurai Y, Kobayashi T, Ono K. 2000. The effects of boron neutron capture therapy on liver tumors and normal hepatocytes in mice. Japan J Cancer Res 91:1058–1064.
   PubMedGoogle Scholar
• van den Aardweg GJ, Naus NC, Verhoeven AC, de Klein A, Luyten GP. 2002. Cellular radiosensitivity of primary and metastatic human uveal melanoma cell lines. Investig Ophthalmol Visual Sci 43:2561–2565.
   PubMed Web of Science ®Google Scholar
• Wambersie A, Menzel HG. 1993. RBE in fast neutron therapy and in boron neutron capture therapy. A useful concept or a misuse? Strahlentherapie und Onkologie 169:57–64.
   PubMedGoogle Scholar
• Wittig A, Sauerwein WA, Coderre JA. 2000. Mechanisms of transport of p-borono-phenylalanine through the cell membrane in vitro. Radiat Res 153:173–180.
   PubMed Web of Science ®Google Scholar
• Yanagisawa N, Ichinoe M, Mikami T, Nakada N, Hana K, Koizumi W, Endou H, Okayasu I. 2012. High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas. J Clin Pathol 65:1019–1023.
   PubMed Web of Science ®Google Scholar
• Yoshida F, Matsumura A, Shibata Y, Yamamoto T, Nakauchi H, Okumura M, Nose T. 2002. Cell cycle dependence of boron uptake from two boron compounds used for clinical neutron capture therapy. Cancer Lett 187:135–141.
   PubMed Web of Science ®Google Scholar